Related Experiment Video
Updated: Jun 4, 2026
08:26
Assessing Activity-based Anorexia in Mice
Published on: May 14, 2018
Pathophysiology and treatment options for cardiac anorexia
Marat Fudim1, Gabriel Wagman, Rebecca Altschul
1Heinrich-Heine-Universität, Düsseldorf, Germany.
Current Heart Failure Reports
|February 18, 2011
Summary
Anorexia-cachexia syndrome (ACS) in heart failure is complex, involving appetite regulation, inflammation, and neurohormones. Current treatments are insufficient, necessitating further research for better cardiac anorexia management.
Area of Science:
- Cardiology
- Metabolic Disorders
- Gastroenterology
Background:
- Anorexia-cachexia syndrome (ACS) is a debilitating condition complicating chronic illnesses, including chronic congestive heart failure (CHF).
- ACS significantly worsens prognosis in CHF patients, yet effective treatments remain elusive.
- Cardiac anorexia, a component of ACS in CHF, presents unique pathophysiological challenges.
Purpose of the Study:
- To review the complex pathophysiology of cardiac anorexia in chronic heart failure.
- To explore the interplay between central appetite regulation, inflammation, and neurohormonal activation in anorexia development.
- To discuss current and future therapeutic strategies for managing cardiac anorexia.
Main Methods:
- Literature review focusing on recent data and established knowledge regarding cardiac anorexia.
- Analysis of the relationship between central appetite control, inflammatory pathways, and neuroendocrine changes.
- Synthesis of information on existing treatment options and emerging therapeutic prospects.
Main Results:
- Cardiac anorexia involves intricate interactions within central appetite-regulating structures.
- Inflammatory processes and neurohormonal activation play critical roles in the development of anorexia in CHF.
- Existing treatments for ACS in CHF offer limited efficacy.
Conclusions:
- Understanding the complex pathophysiology of cardiac anorexia is crucial for improving patient outcomes in CHF.
- Targeting central appetite regulation, inflammation, and neurohormonal pathways may offer novel therapeutic avenues.
- Further research is essential to develop effective management strategies for anorexia-cachexia syndrome in heart failure.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Anorexia Nervosa
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...